PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
A Comprehensive Look at Sarepta's Growth and Innovation
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
PTC Therapeutics Provides Key Regulatory Updates
PTC Therapeutics, Inc. (NASDAQ:PTCT) Just Released Its Yearly Earnings: Here's What Analysts Think
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.